Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-25823.01%
operating margin TTM
-26383.53%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.29 |
| peg ratio | -0.02 |
| price to book ratio | 0.18 |
| price to sales ratio | 76.68 |
| enterprise value multiple | -0.42 |
| price fair value | 0.18 |
profitability ratios | |
|---|---|
| gross profit margin | -132.05% |
| operating profit margin | -26383.53% |
| pretax profit margin | -26382.43% |
| net profit margin | -25823.01% |
| return on assets | -31.54% |
| return on equity | -61.66% |
| return on capital employed | -54.25% |
liquidity ratios | |
|---|---|
| current ratio | 0.47 |
| quick ratio | 0.14 |
| cash ratio | 0.12 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 20,384.61 |
| operating cycle | 20,384.61 |
| days of payables outstanding | 11,956.74 |
| cash conversion cycle | 8,427.87 |
| receivables turnover | 0.00 |
| payables turnover | 0.03 |
| inventory turnover | 0.02 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | -238.82 |
| cash flow to debt ratio | -23.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.87 |
| cash per share | 0.55 |
| operating cash flow per share | -1.87 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -23.35 |
| short term coverage ratios | -179.47 |
| capital expenditure coverage ratio | -5,146,159.00 |
Frequently Asked Questions
When was the last time Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) reported earnings?
Citius Pharmaceuticals, Inc. (CTXR) published its most recent earnings results on 12-08-2025.
What is Citius Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)'s trailing twelve months ROE is -61.66%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Citius Pharmaceuticals, Inc. (CTXR) currently has a ROA of -31.54%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CTXR's net profit margin stand at?
CTXR reported a profit margin of -25823.01% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CTXR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.47 in the most recent quarter. The quick ratio stood at 0.14, with a Debt/Eq ratio of 0.01.